Clinical trial

Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients…

NCT00008164 · Herbert Irving Comprehensive Cancer Center, Other · Unknown status

Key facts

NCT number NCT00008164
Title Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
Official title Transplantation Using Umbilical Cord And Placental Blood
Lead sponsor Herbert Irving Comprehensive Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH
Status Unknown status
Phase Phase 2
Study type Interventional
Conditions Childhood Langerhans Cell Histiocytosis, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
Intervention type Procedure
Interventions umbilical cord blood transplantation
Enrollment 30
Start date Jan 1, 1997
First posted Jan 27, 2003
Last update posted Dec 18, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies